STAGE III PLEURAL MALIGNANT MESOTHELIOMA AJCC V8

Clinical trials for STAGE III PLEURAL MALIGNANT MESOTHELIOMA AJCC V8 explained in plain language.

Never miss a new study

Get alerted when new STAGE III PLEURAL MALIGNANT MESOTHELIOMA AJCC V8 trials appear

Sign up with your email to follow new studies for STAGE III PLEURAL MALIGNANT MESOTHELIOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Scientists test new weapon to attack advanced cancers

Disease control Ongoing

This early-stage trial is testing a new drug called BAY 1895344, given alongside standard chemotherapy drugs, in people with advanced solid tumors that have spread. The main goal is to find the safest and most effective dose of this combination. Researchers are especially interes…

Matched conditions: STAGE III PLEURAL MALIGNANT MESOTHELIOMA AJCC V8

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

STAGE III PLEURAL MALIGNANT MESOTHELIOMA AJCC V8

Get alerted when new STAGE III PLEURAL MALIGNANT MESOTHELIOMA AJCC V8 trials appear

Scientists test new weapon to attack advanced cancers